Focus: RapidPulse is a Miami-based biotech company developing the RapidPulse™ Cyclic Aspiration System, a medical device for acute ischemic stroke treatment. The company operates as a focused device innovator in the neurology and cardiovascular space.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
No open roles listed right now. Follow RapidPulse to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Single flagship device in development; clinical validation ongoing with 1 trial identified, positioning as mechanical thrombectomy alternative.
Help build intelligence for RapidPulse
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from RapidPulse's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo